Taken together, our findingsdemonstrated that KLF5-regulated RP1 plays anoncogenic role in breast cancer by suppressing p27kip1, providing support for theclinical investigation of therapeutic approaches focusing on RP1. Here, CDKN1B is linked to breast cancer.